Cardiovascular Disease, Hypogonadism and ED: Early Detection, Prevention and the Positive Effects of Long-Term TRT

Author: National Library of Medicine
Cardiovascular Disease, Hypogonadism and ED: Early Detection, Prevention and the Positive Effects of Long-Term TRT

In this prospective longitudinal study of 622 men on TRT: erectile function increased significantly, average weight loss was 23.6 ± 0.6 kg after 8 years, blood glucose readings improved and several patients with diabetes went into remission.  Cholesterol levels improved significantly and systolic blood pressure decreased by 33±1 mmHg on average.

Purpose

Erectile dysfunction (ED) is associated with testosterone deficiency and is a symptom of functional hypogonadism. A correlation between ED and cardiovascular disease (CVD) has been recognized, and ED has been proposed as an early marker of CVD. However, the relationship between ED and CVD risk in hypogonadism requires clarification and whether testosterone therapy (TTh) can be a beneficial treatment strategy, but long-term data are limited. This study investigates long-term TTh in men with hypogonadism and ED with a history of CVD.

Methods

Seventy-seven patients with a history of CVD and diagnosed with functional hypogonadism and erectile dysfunction (erectile function domain score <21 on the International Index of Erectile Function questionnaire (IIEF questions 1–5)) were enrolled and TTh effects on anthropometric and metabolic parameters investigated for a maximum duration of 12 years. All men received long-acting injections of testosterone undecanoate at 3-monthly intervals. Eight-year data were analysed. Data collection registry started in November 2004 till January 2015.

Results

In hypogonadal men receiving TTh, IIEF increased by 5.4 (p<0.001). Total weight loss was 23.6 ± 0.6 kg after 8 years. HbA1c had declined by an average of 2.0% (P<0.0001). Total cholesterol levels significantly declined following TTh after only 1 year (P<0.0001), and HDL increased from 1.6±0.5 at baseline to 2±0.5 mmol/L following 8 years of TTh (P<0.0001). SBP decreased from 164±14 at baseline to 133±9 mmHg, signifying a reduction of 33±1 mmHg (P<0.0001).

Conclusion

In hypogonadal men with a history of CVD, TTh improves and preserves erectile function over prolonged periods with concurrent sustained improvements in cardiometabolic risk factors. Measuring ED and testosterone status may serve as an important male health indicator predicting subsequent CVD-related events and mortality and TTh may be an effective add-on treatment in secondary prevention of cardiovascular events in hypogonadal men with a history of CVD.


https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8403087/

Have Questions?

Ask us about TRT, medical weightloss, ED, or other men's health topics.

Ask Now

People are asking...

How long does using trt, or using full cycles take to from a blockage or, worsen a blockage of the heart?...

TRT does not increase risk of heart attack at all. In fact, it seems to reduce the risk TRT has been proven to lower cholesterol Long term TRT has been proven to cause significant reductions in s... See Full Answer

My friend was in the hospital for CHF with mild ejection fraction and no clots. All good markers are good and Ejection fraction is now normal. Can be ...

The science is pretty clear on the fact that low testosterone is a greater risk factor for heart disease and CHF than TRT. The latest research on the matter shows that TRT is cardioprotective and impr... See Full Answer

I see people post on various threads on steroids and how they age substantially in a few years. Does TRT have similar effects or is that more hardcore...

For traditional TRT, aka non-bodybuilding levels of Testosterone, this is almost what we would consider the opposite. Testosterone in men helps to maintain metabolism & low Testosterone often leads to... See Full Answer

Get $30 off your first month’s order

Enter your email address now to receive $30 off your first month’s cost, other discounts, and additional information about TRT.

Legal Disclaimer

This website is a repository of publicly available information and is not intended to form a physician-patient relationship with any individual. The content of this website is for informational purposes only. The information presented on this website is not intended to take the place of your personal physician's advice and is not intended to diagnose, treat, cure, or prevent any disease. Discuss this information with your own physician or healthcare provider to determine what is right for you. All information is intended for your general knowledge only and is not a substitute for medical advice or treatment for specific medical conditions. The information contained herein is presented in summary form only and intended to provide broad consumer understanding and knowledge. The information should not be considered complete and should not be used in place of a visit, phone or telemedicine call, consultation or advice of your physician or other healthcare provider. Only a qualified physician in your state can determine if you qualify for and should undertake treatment.